Combination of Omacetaxine Mepesuccinate (homoharringtonine) and Sorafenib As an Effective Regimen for Acute Myeloid Leukemia (AML) Carrying FLT3-ITD

被引：0
作者：
Leung, Garret M. K.
Zhang, Chunxiao
To, Alan W. L.
Lam, Stephen S. Y.
Kwong, Yok Lam
Leung, Anskar
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3849
引用
收藏
页数：2
相关论文
共 50 条
  • [41] PRE-CLINICAL EVALUATION OF NOVEL FLT3 INHIBITORS EFFECTIVE IN FLT3-ITD ACUTE MYELOID LEUKEMIA
    Minson, Katherine
    Sherick, Alisa Lee
    DeRyckere, Deborah
    Wang, Xiaodong
    Frye, Stephen
    Earp, H. Shelton, III
    Graham, Doug
    [J]. PEDIATRIC BLOOD & CANCER, 2014, 61 : S52 - S52
  • [42] The Diversity of FLT3-ITD and the Prognostic Impact in Adult Acute Myeloid Leukemia
    Yang, Jingyi
    Mo, Shanlan
    Wei, Xudong
    Lv, Xiaodong
    Fang, Baijun
    Zhang, Yanli
    Zhou, Jian
    Zhou, Hu
    Fu, Yuewen
    Lin, Quande
    Liu, Delong
    Song, Yongping
    Wang, Qianfei
    Zhou, Keshu
    [J]. BLOOD, 2023, 142
  • [43] Clinical importance of mutation types of FLT3-ITD in acute myeloid leukemia
    Kim, Seon Young
    Park, Yun Mi
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 551 - 551
  • [44] Validation of FLT3-ITD As a Therapeutic Target in Human Acute Myeloid Leukemia
    Smith, Catherine C.
    Chin, Jason
    Wang, Qi
    Salerno, Sara
    Damon, Lauren E.
    Hunt, Jeremy P.
    Levis, Mark J.
    Perl, Alexander E.
    Travers, Kevin
    Wang, Susana
    Kasarskis, Andrew
    Schadt, Eric
    Kuriyan, John
    Shah, Neil
    [J]. BLOOD, 2011, 118 (21) : 426 - 427
  • [45] Targeting BTK for the treatment of FLT3-ITD mutated acute myeloid leukemia
    Genevra Pillinger
    Amina Abdul-Aziz
    Lyubov Zaitseva
    Matthew Lawes
    David J. MacEwan
    Kristian M. Bowles
    Stuart A. Rushworth
    [J]. Scientific Reports, 5
  • [46] Prognostic Value of FLT3-ITD Residual Disease in Acute Myeloid Leukemia
    Vonk, Christian
    Grob, Tim
    Sanders, Mathijs
    Kavelaars, Francois
    Rijken, Melissa
    Hanekamp, Diana
    Gradowska, Patrycja
    Cloos, Jaqueline
    Floisand, Yngvar
    Kooy, Marinus Van Marwijk
    Manz, Markus
    Ossenkoppele, Gert
    Tick, Lidwine
    Vekemans, Marie-Christiane
    Lowenberg, Bob
    Jongen-Lavrencic, Mojca
    Valk, Peter
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S227 - S227
  • [47] FLT3-ITD As a Prognostic Factor for Chinese Patients with Acute Myeloid Leukemia
    Sun, Jie
    He, Jingsong
    Wei, Guoqing
    Zheng, Weiyan
    Shi, Jimin
    Luo, Yi
    Huang, He
    [J]. BLOOD, 2016, 128 (22)
  • [48] FLT3-ITD regulation of the endoplasmic reticulum functions in acute myeloid leukemia
    Turos-Cabal, Maria
    Sanchez-Sanchez, Ana M.
    Puente-Moncada, Noelia
    Herrera, Federico
    Antolin, Isaac
    Rodriguez, Carmen
    Martin, Vanesa
    [J]. HEMATOLOGICAL ONCOLOGY, 2024, 42 (03)
  • [49] ACC010, a novel BRD4 inhibitor, synergized with homoharringtonine in acute myeloid leukemia with FLT3-ITD
    Qian, Yu
    Zhang, Xiang
    Mao, Shihui
    Wei, Wenwen
    Lin, Xiangjie
    Ling, Qing
    Ye, Wenle
    Li, Fenglin
    Pan, Jiajia
    Zhou, Yutong
    Zhao, Yanchun
    Huang, Xin
    Huang, Jiansong
    Tong, Hongyan
    Sun, Jie
    Jin, Jie
    [J]. MOLECULAR ONCOLOGY, 2023, 17 (07) : 1402 - 1418
  • [50] Pitfalls in molecular standardization for detection of FLT3-ITD in acute myeloid leukemia
    da Costa, Juliana B.
    Naressi, Rafaella G.
    Ramires, Jordana
    Vianna, Danielle T.
    Teles, Juliana A.
    Padilha, Telma F.
    Monte-Mor, Barbara da C. R.
    Zalcberg, Ilana
    Gutiyama, Luciana M.
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2023, 45 (04) : 581 - 585
12345